Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Solvotrin Therapeutics

Solvotrin Therapeutics
2009 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Grant LATEST DEAL TYPE
$68.1K LATEST DEAL AMOUNT
3 INVESTORS
Description

Operator of a drug development platform designed to focus on developing drugs for the cardiovascular market. The company's platform develops drugs with the focus on optimizing established therapies, vitamins and minerals which help in the management of iron deficiency and gastric problems associated with traditional aspirin, enabling clients to get more effective medicines.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • Hoffmann Park
  • Inchera, Little Island
  • Cork
  • Ireland

+353 (021) 000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Solvotrin Therapeutics’s full profile, request a free trial.

Solvotrin Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 13-Nov-2012 $68.1K 00.000 Completed Startup
1. Early Stage VC 01-Jul-2011 00.000 00.000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Solvotrin Therapeutics Competitors (7)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cambrex Corporation East Rutherford, NJ 0000 000000000000
00000 & 00. Corporation Kenilworth, NJ 00000
000000000000000 Corporation Brentford, United Kingdom 000000 00000000000
000000 00000000 Formerly VC-backed Foster City, CA 00000 00.000 000000000 00.000
00000000 Corporate Backed or Acquired Basel, Switzerland 000000 000000000000
To view this company’s complete list of competitors, request access »

Solvotrin Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
InterTradeIreland Corporation 000 0000 000000 0
Elkstone Partners Family Office Minority 000 0000 000000 0
Enterprise Ireland Government Minority 000 0000 000000 0

Solvotrin Therapeutics Executive Team (4)

Name Title Board
Seat
Contact
Info
Pat O'Flynn Co-Founder, Chief Executive Officer and President
George Walsh Chief Financial Officer
Mark Ledwidge Ph.D Co-Founder & Vice President, Development & Strategy
John Gilmer Vice President, Research & Development & Co-Founder

Solvotrin Therapeutics Board Members (1)

Name Representing Role Since Contact
Info
Diarmuid Burke Solvotrin Therapeutics Board Member 000 0000